ReproTech Responds

View the FAQs for Patients Related to COVID-19 from the American Society of Reproductive Medicine (ASRM).

A message to our Valued Clients:

Because ReproTech provides a critical service to our clients, we understand that many of you may be concerned how COVID-19 could impact our operations and how that would affect the precious specimens that we store for you. For everyone’s safety, ReproTech will segregate and store specimens from people who have tested positive for COVID-19 in separate vapor tanks, similar to how we already handle other potentially infectious storage. 

At this time, there have been no changes to ReproTech’s specimen protocols or shipping capability and we remain fully staffed. Our storage tanks are replenished manually with liquid nitrogen to maintain their temperatures, so they do not need electricity, and our tank monitoring systems are backed up by battery power and tested frequently.

ReproTech has always been concerned about the health of our employees. Paid sick time and 100% paid health insurance premiums are provided for all our employees. Some of our staff are working from home, so you may hear children, pets or other household sounds in the background during phone calls. Know that these are not our usual office sounds and bear with us through these unusual times.

In response to COVID-19 transmission, we have implemented a number of precautions in the workplace. We are rotating onsite staff to reduce the number of employees in the workplace at the same time. Most importantly, if any employee feels sick, they are required to stay home and seek medical care if needed, helping to keep their co-workers healthy and on the job. We know it is important that we take care of the employees who take care of your irreplaceable specimens.

ReproTech will continue to offer exceptional customer service and be available to provide critical business functions. Rest assured that we will have dedicated ReproTech staff available at all times to maintain storage tanks and ensure all specimens remain safe.

We continue to follow the impact of COVID-19 infections in the United States and will keep you updated with any company developments on this website.